A study to Learn If Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults.
This research study is for healthy adults and is trying to understand if certain medicines affect each other when taken together. Specifically, scientists want to find out how two existing medicines, Cyclosporine and Clarithromycin, might influence the way your body processes a new experimental medicine called PF-07328948. It's important to understand these interactions to make sure new medicines are safe and effective when people need to take multiple medications. This type of study, often called a Phase I study, is one of the first steps in testing new medicines in people. The goal is to gather information about how the medicines behave in the body, not to treat any specific illness like heart failure. Participants will be healthy adults.
At a glance
What is this study about?
Imagine your body is like a finely tuned machine, and when you take medicines, they travel through it. Sometimes, different medicines can affect how others work – speeding them up, slowing them down, or changing how much of them stays in your system. This study is designed to explore exactly that: how two commonly used medicines, Cyclosporine and Clarithromycin, might affect a new medicine called PF-07328948.
Cyclosporine is a medicine often used to calm down the immune system, for example, after an organ transplant. Clarithromycin is an antibiotic used to treat various infections. The new medicine, PF-07328948, is still in early development, but the researchers are thinking ahead to understand how it might interact with other treatments people commonly use.
By understanding these interactions in healthy volunteers, researchers can get a clearer picture of how PF-07328948 might behave in a real-world situation where patients might need to take several medications at once. This information is crucial for developing safe and effective new treatments in the future, particularly for conditions they are hoping to treat, like heart failure, where patients often take many different medicines.
Key takeaways
- This study looks at how two existing medicines (Cyclosporine, Clarithromycin) affect a new medicine (PF-07328948).
- It's for healthy adults, aged 18 and over, both men and women.
- The goal is to understand medicine interactions, not to treat any illness.
- Participants will take study medicines and have regular health checks, including blood tests.
- Taking part helps advance medical knowledge for future treatments.
- You can stop participating at any time if you change your mind.
Who may be eligible?
This study is looking for healthy adults. You would need to be at least 18 years old to take part, and there's no upper age limit mentioned. Both men and women are welcome to participate.
The main idea is to study how medicines behave in a healthy body before moving on to studies in people who are unwell. Therefore, you would need to be generally healthy and not have any serious ongoing medical conditions.
Specific details about health checks, current medications, or lifestyle choices will be discussed with you by the research team. They will carry out thorough assessments to make sure it's safe for you to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally healthy with no serious ongoing medical conditions?
- Are you willing to take specific study medicines as instructed?
- Are you happy to attend clinic visits for tests and monitoring?
- Are you able to understand and follow study instructions?
What does participation involve?
Taking part in this study would involve several visits to a clinic. You would likely be asked to take specific doses of the study medicines – Cyclosporine, Clarithromycin, and PF-07328948 – sometimes one at a time, and sometimes together, following a set schedule. The team would carefully monitor you throughout.
During your visits, you would have regular health checks. This could include things like blood tests to see how your body is processing the medicines, checking your vital signs (like blood pressure and heart rate), and possibly providing urine samples. There would also be check-ups to make sure you are feeling well.
The exact number and length of visits, and how long the study would last for you overall, would be explained in full by the research team. You would also have follow-up contact after you've finished taking the medicines to ensure your health is still good.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What is PF-07328948?
PF-07328948 is a new medicine that is being tested. This study is an early step to understand how it works in the body and if it interacts with other medicines.
Why are healthy people needed for this study?
Healthy volunteers help researchers understand how medicines behave in a 'normal' body without other illnesses masking the effects. This information is crucial before testing medicines in people who are unwell.
Will I be given treatment for heart failure in this study?
No, this study is about understanding how medicines interact, not about treating heart failure. Participants must be healthy.
Will I be paid for taking part?
This information is not provided, but some studies offer reimbursement for time and travel. You should ask the study team about this.
What happens if I feel unwell during the study?
The study team will monitor you closely. If you feel unwell, you should tell them immediately. Your safety is their top priority.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.